EUVIMEDEUVIMED entdecken
Crossref

Stability of Hybridoma Cell Line Clone 4C91F9 Secreting Anti-E Monoclonal Antibody

Siriporn Ponsen, Nootchanat Premprayoon, Dussadee Phoreekul

Journal of Health Science and Alternative Medicine · 31.12.2023

DOI: 10.14456/jhsam.2023.17 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Health Science and Alternative Medicine, erschienen am 31.12.2023. Verfasst von Siriporn Ponsen und 2 weiteren Autor:innen.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Since 2018, the Antiserum and Standard Cell Preparation Section, National Blood Center, Thai Red Cross Society (NBC) have succeeded in producing a hybridoma cell line secreted anti-E with a good antibody titer and suitable for blood grouping reagent anti-E production. At first, we established 4 different human monoclonal hybridoma IgM cell lines stably expressing anti-E, namely 4C91A2, 4C91B9, 4C91F9, and 4C91G5, respectively. After that, 4 different cell lines were selected only the perfect one with good growth rate and high titer antibody character. Finally, a clone namely 4C91F9 was selected for culture on a large scale and its supernatant was collected for blood grouping reagent anti-E production. So, we must ensure the 4C91F9 cell line has good antibody titer production stability in the long run. The study aimed to detect the stability of hybridoma cell line clone 4C91F9 secreting anti-E monoclonal antibody from 1st to 3rd generation.

Methods

The cell line clone 4C91F9 secreting 1st generation anti-E was thawed from liquid nitrogen and selected to be the best single cell line with a good growth rate and high titer antibody secretion tested by limiting dilution method. Afterward, the selected cell line will be frozen in liquid nitrogen for 7 days. In addition, the 1st generation cell line that separated from freezing was cultured to harvest supernatant subjected to further serologic testing. The 2nd generation cell line was thawed after being frozen for 7 days for the limit dilution method again until 3rd generation. Serological testing for supernatant from all generation cell lines consisted of antibody identification with panel cells and antibody titration (potency) with R1R2, R1Rz, and r”r red blood cell group O. Also, a specificity test with antigen E positive and antigen E negative red blood cells was performed.

Results

Anti-E antibodies from all three generations of clone 4C91F9 showed perfect stability with high titer. Titers of 512, 1024, and 1024 were obtained at room temperature, and 512, 512, and 512 were obtained at the indirect antiglobulin test (IAT), respectively.

Conclusion

The characteristics of all generations of anti-E production are comparable to the American Association of Blood Banks (AABB) standard. This result confirms the quality of the anti-E monoclonal antibody suitable for being a blood typing reagent produced by Nation Blood Center, Thai Red Cross Society to ensure the safety of the blood donation and transfer process.

Schlagwörter

hybridomared cell antigensantibody specificityantibody potencymonoclonal IgMRh blood group systemindirect antiglobulin test

Zitieren

APA

Ponsen, S., Premprayoon, N., & Phoreekul, D. (2023). Stability of Hybridoma Cell Line Clone 4C91F9 Secreting Anti-E Monoclonal Antibody. Journal of Health Science and Alternative Medicine. https://doi.org/10.14456/jhsam.2023.17

Vancouver

Ponsen S, Premprayoon N, Phoreekul D. Stability of Hybridoma Cell Line Clone 4C91F9 Secreting Anti-E Monoclonal Antibody. Journal of Health Science and Alternative Medicine. 2023. doi:10.14456/jhsam.2023.17

BibTeX
@article{Ponsen2023,
  author = {Ponsen, Siriporn and Premprayoon, Nootchanat and Phoreekul, Dussadee},
  title = {Stability of Hybridoma Cell Line Clone 4C91F9 Secreting Anti-E Monoclonal Antibody},
  journal = {Journal of Health Science and Alternative Medicine},
  year = {2023},
  doi = {10.14456/jhsam.2023.17}
}
Kostenlos starten →